A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use. In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.
This report contains market size and forecasts of Nuclear Medicine Isotopes in Global, including the following market information:
Global Nuclear Medicine Isotopes Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Nuclear Medicine Isotopes market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stable Isotopes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nuclear Medicine Isotopes include NRG, NTP Radioisotopes, JSC Isotope, ANSTO, IRE, Nordion, Curium Pharma, Cambridge Isotope Laboratories and Eckert & Ziegler Strahlen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nuclear Medicine Isotopes companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Medicine Isotopes Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Nuclear Medicine Isotopes Market Segment Percentages, by Type, 2021 (%)
Stable Isotopes
Radioisotopes
Global Nuclear Medicine Isotopes Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Nuclear Medicine Isotopes Market Segment Percentages, by Application, 2021 (%)
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Global Nuclear Medicine Isotopes Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Nuclear Medicine Isotopes Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nuclear Medicine Isotopes revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Nuclear Medicine Isotopes revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
IRE
Nordion
Curium Pharma
Cambridge Isotope Laboratories
Eckert & Ziegler Strahlen
Polatom
Center of Molecular Research
China National Nuclear Corporation
Urenco
LANL
Shanghai Engineering Research Center
IDB Holland
NHTC
Linde
ORNL
SI Science